Insider Transactions in Q2 2024 at Checkpoint Therapeutics, Inc. (CKPT)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 26
2024
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,038
-1.9%
|
$26,076
$2.06 P/Share
|
Jun 26
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Bona fide gift
|
Direct |
37,890
-1.92%
|
-
|
Jun 26
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
24,610
-1.23%
|
$49,220
$2.05 P/Share
|
May 24
2024
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,660,000
+45.33%
|
-
|
May 24
2024
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
540,000
+44.07%
|
-
|
May 14
2024
|
Sharma Amit Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,051
+28.09%
|
-
|
May 14
2024
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
82,051
+32.42%
|
-
|
May 14
2024
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.79%
|
-
|
May 14
2024
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.11%
|
-
|
May 14
2024
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+27.75%
|
-
|
May 14
2024
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.11%
|
-
|